Amble Tirzepatide Cost: 2026 Plans, Dose Pricing and Extra Fees

Last reviewed: September 13, 2026 Last updated: September 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Amble prices compounded tirzepatide injections in two dose tiers: $289 per month for low doses (2.5–5 mg) and $329 per month for higher doses (7.5–15 mg), billed monthly with no membership fee (captured September 4, 2026 from Amble's FAQ). That $40 step-up means a patient who titrates to 10 mg pays $3,948 over twelve months—$480 more than the starter-dose year. PlexusDx charges $289 per month for tirzepatide at every dose on month-to-month billing, and $269 or $249 per month on prepaid three- or six-month commitments. If you expect to reach a maintenance dose above 5 mg, Amble's dose-tier structure adds measurable cost; if you stay at a low dose the programs tie at $289 month-to-month, and PlexusDx pulls ahead with prepaid plans.

At-a-glance: Amble vs PlexusDx tirzepatide pricing

All figures verified September 2026. Amble pricing captured from Amble FAQ (September 4, 2026); PlexusDx pricing captured from PlexusDx product pages (July 2026). 12-month totals are our calculation.

Amble tirzepatide pricing: two-tier dose structure

Amble divides compounded tirzepatide injections into a low-dose tier (2.5 mg and 5 mg) at $289 per month and a high-dose tier (7.5 mg, 10 mg, 12.5 mg, and 15 mg) at $329 per month, both billed monthly with no membership fee. The pricing is described as all-inclusive—medication, provider consultation, and shipping—though because the primary source is a Canva-hosted FAQ (https://amblefaq-glp1support.my.canva.site/), we recommend confirming the exact fee structure at checkout.

The $40 step-up between tiers adds $480 to a twelve-month cost once you move above 5 mg. A patient who starts at 2.5 mg and titrates to 10 mg over three months would pay $289 × 3 = $867 during titration and $329 × 9 = $2,961 at maintenance, for a first-year total of $3,828 (our calculation). A patient who reaches 15 mg and holds that dose for nine months sees the same $3,828 total. If you stay at 2.5 mg or 5 mg for the entire year, the total is $3,468.

PlexusDx tirzepatide pricing: flat rate across all doses

PlexusDx charges $289 per month for compounded tirzepatide injection at every dose—2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg—on month-to-month billing. A patient who titrates to 10 mg or 15 mg pays the same $289 monthly rate as someone on the starter dose, for a twelve-month total of $3,468 (our calculation).

Prepaid commitments lower the per-month rate: three-month billing runs $269 per month ($807 per quarter, $3,228 over twelve months; our calculation) and six-month billing runs $249 per month ($1,494 per half-year, $2,988 over twelve months; our calculation). The prepaid rates apply equally at all doses. There is no membership fee, and the published price includes the provider visit, prescription, compounded medication, and shipping.

Like-for-like comparison: monthly billing

On monthly billing—the only plan structure Amble offers—Amble and PlexusDx tie at $289 per month and $3,468 per year if you remain on a low dose (2.5–5 mg). Once your provider prescribes 7.5 mg or higher, Amble's rate steps to $329 per month and the twelve-month gap opens:

• Amble high dose: $329/month × 12 = $3,948 (our calculation)
• PlexusDx month-to-month: $289/month × 12 = $3,468 (our calculation)
• Annual difference: $480 in favor of PlexusDx (our calculation)

If you titrate mid-year—say, three months at low dose and nine months at high dose—Amble runs $3,828 versus PlexusDx's flat $3,468, a $360 difference (our calculation).

PlexusDx prepaid plans vs Amble monthly

PlexusDx offers two prepaid commitments that lower the per-month rate at every dose tier:

• 3-month prepaid: $269/month ($807 per quarter), $3,228 over twelve months (our calculation)—$720 less than Amble high dose, $240 less than Amble low dose.
• 6-month prepaid: $249/month ($1,494 per half-year), $2,988 over twelve months (our calculation)—$960 less than Amble high dose, $480 less than Amble low dose.

These are like-for-like comparisons only in the sense that both providers offer compounded tirzepatide injections; Amble publishes no multi-month prepaid option, so the billing structures differ. The prepaid figures are per-month equivalents of lump-sum payments and are our calculation.

What Amble's all-inclusive pricing includes

Amble describes its tirzepatide pricing as all-inclusive with no membership fee. The FAQ specifies that the monthly rate covers the provider consultation, prescription, compounded medication, and shipping. We saw no mention of separate lab fees, onboarding charges, or cancellation penalties in the captured evidence (September 4, 2026), but because the source is a third-party-hosted FAQ rather than a Terms of Service page, we recommend reviewing the final invoice at checkout and asking support about any fees not listed in the FAQ.

What PlexusDx pricing includes

PlexusDx publishes a single monthly price—$289 month-to-month, $269 on three-month billing, $249 on six-month billing—that includes the online provider visit, electronic prescription, compounded tirzepatide injection at the prescribed dose, and shipping to your address. There is no membership fee, no separate consultation charge, and no hidden add-ons. Labs and follow-up visits are included when clinically indicated; the provider determines the monitoring schedule during your intake review.

Dose-tier cost over a typical titration schedule

Most tirzepatide protocols start at 2.5 mg and increase by 2.5 mg every four weeks if tolerated, reaching a maintenance dose between 5 mg and 15 mg by month four or five. Under Amble's two-tier pricing, a patient who follows a standard titration and settles at 10 mg would pay:

• Month 1 (2.5 mg): $289
• Month 2 (5 mg): $289
• Month 3 (7.5 mg): $329 (tier step-up)
• Months 4–12 (10 mg): $329 × 9 = $2,961
• First-year total: $3,828 (our calculation)

Under PlexusDx flat pricing, the same patient pays $289 every month regardless of dose, for a first-year total of $3,468 (our calculation)—a $360 difference. On the PlexusDx six-month prepaid plan, the total falls to $2,988 (our calculation), $840 below the Amble titration cost.

Medication form, route, and regulatory status

Both Amble and PlexusDx offer compounded tirzepatide as a subcutaneous injection delivered in pre-filled or patient-filled syringes (or auto-injector pens where available). Neither provider prescribes FDA-approved Mounjaro or Zepbound under these published price points; the medications are compounded by 503A pharmacies and are not FDA-approved. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Semaglutide pricing context

For comparison, Amble charges an introductory first-month rate of $179 for compounded semaglutide injection at all doses, with a standard ongoing rate of $289 per month after the first month (captured September 4, 2026). PlexusDx charges $189 per month for semaglutide injection on month-to-month billing, $169 per month on three-month prepaid, and $149 per month on six-month prepaid. The semaglutide pricing gap is narrower than the tirzepatide gap, and Amble holds the month-to-month advantage by $10 per month on semaglutide after the introductory period.

Choose Amble if…

• You expect to stay on a low tirzepatide dose (2.5 mg or 5 mg) indefinitely and prefer simple monthly billing with no multi-month commitment.
• You want semaglutide instead and can benefit from the first-month introductory rate before moving to the standard ongoing price.
• You value a streamlined FAQ-based support model and are comfortable confirming fee details at checkout.

Choose PlexusDx if…

• Your provider expects you to titrate above 5 mg and you want to avoid the $40/month tier step-up—PlexusDx holds tirzepatide at $289/month at every dose.
• You're willing to prepay three or six months to lock in $269/month or $249/month (our calculation), saving $240–$960 per year compared to Amble's high-dose tier.
• You want transparent, publicly documented pricing with verified review data (PlexusDx holds a 4.3-star rating on Trustpilot with 79% five-star reviews and 83% four stars or higher, captured September 9, 2026).
• You prefer a provider that publishes detailed Terms of Service and fee breakdowns on its own domain rather than a third-party FAQ host.

Methodology and freshness

We captured Amble's tirzepatide pricing from the provider's public FAQ hosted at https://amblefaq-glp1support.my.canva.site/ on September 4, 2026. Because the FAQ is hosted on a third-party platform (Canva), we note that pricing and terms should be confirmed at checkout or by contacting Amble support directly. PlexusDx pricing was captured from the provider's product pages between July 17 and July 23, 2026. All twelve-month totals, per-month prepaid equivalents, titration scenarios, and cost differences are our calculation and are labeled as such. We apply identical evidence standards to PlexusDx and competing programs. No promotional codes, affiliate incentives, or undisclosed commercial relationships influenced this analysis.

Frequently Asked Questions

Does Amble charge more when my tirzepatide dose goes up?

Yes. Amble divides tirzepatide into two pricing tiers: $289 per month for 2.5 mg and 5 mg, and $329 per month for 7.5 mg through 15 mg. Once your provider prescribes a dose above 5 mg, your monthly rate increases by $40, adding $480 to your twelve-month cost (our calculation). PlexusDx charges $289 per month at every dose on month-to-month billing.

Are there any hidden fees in Amble's all-inclusive tirzepatide price?

Amble describes its pricing as all-inclusive with no membership fee, and the FAQ states that the monthly rate covers the provider visit, prescription, medication, and shipping (captured September 4, 2026). We saw no mention of lab fees, cancellation charges, or onboarding costs in the evidence. Because the source is a Canva-hosted FAQ, confirm the complete fee schedule at checkout or by contacting Amble support.

How much do I save with PlexusDx prepaid tirzepatide plans compared to Amble?

If you move to Amble's high-dose tier ($329/month), PlexusDx's three-month prepaid plan ($269/month; our calculation) saves $720 over twelve months, and the six-month prepaid plan ($249/month; our calculation) saves $960 over twelve months. Even against Amble's low-dose tier, the six-month plan saves $480 per year (our calculation). These figures assume you complete the prepaid cycles.

Does Amble offer discounts for paying multiple months upfront?

No multi-month prepaid option appears in the captured evidence (September 4, 2026). Amble publishes only monthly billing at $289 for low-dose tirzepatide and $329 for high-dose tirzepatide. If you want a lower per-month rate in exchange for a longer commitment, PlexusDx offers three-month and six-month prepaid cycles at $269/month and $249/month respectively (our calculation).

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is prepared by a compounding pharmacy using the same active ingredient as branded Mounjaro and Zepbound, but compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. A licensed clinician determines whether a compounded prescription is appropriate for your individual situation. Neither Amble nor PlexusDx dispenses FDA-approved Mounjaro or Zepbound under these pricing structures.

Sources

• PlexusDx tirzepatide product page (https://plexusdx.com/products/tirzepatide-injection), accessed July 17–23, 2026
• Amble GLP-1 Support FAQ (https://amblefaq-glp1support.my.canva.site/), accessed September 4, 2026
• PlexusDx Trustpilot profile (https://www.trustpilot.com/review/plexusdx.com), accessed September 9, 2026
• Amble Trustpilot profile (https://www.trustpilot.com/review/joinamble.com), accessed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.